Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab

Maki Yoshino(Tokyo Women's Medical University Adachi Medical Center), Toshio Takagi(Tokyo Women's Medical University), Kazutaka Nakamura(Tokyo Women's Medical University Hospital), Daisuke Toki(Tokyo Women's Medical University Adachi Medical Center), Hidekazu Tachibana, Hirohito Kobayashi(Ebina General Hospital), Kazuhiko Yoshida(Tokyo Women's Medical University Hospital), Tsunenori Kondo(Tokyo Women's Medical University Adachi Medical Center), Hironori Fukuda(Tokyo Women's Medical University), Hiroki Ishihara(Tokyo Women's Medical University), Yasunobu Hashimoto, Yuki Nemoto(Tokyo Women's Medical University Adachi Medical Center), Hiroaki Shimmura(Jyoban Hospital of Tokiwa Foundation), Junpei Iizuka(Tokyo Women's Medical University), Kazunari Tanabe(Shonan Kamakura General Hospital), Koichi Nishimura(Tokyo Women's Medical University Adachi Medical Center)
Japanese Journal of Clinical Oncology
July 2, 2022
Cited by 16


Related Papers